nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—Temozolomide—brain cancer	0.119	0.486	CbGbCtD
Isradipine—CYP3A4—Lomustine—brain cancer	0.101	0.414	CbGbCtD
Isradipine—CACNA1D—cochlea—brain cancer	0.0369	0.142	CbGeAlD
Isradipine—CACNA1D—internal ear—brain cancer	0.035	0.134	CbGeAlD
Isradipine—CYP3A4—Etoposide—brain cancer	0.0244	0.1	CbGbCtD
Isradipine—Throat sore—Lomustine—brain cancer	0.014	0.0295	CcSEcCtD
Isradipine—Oropharyngeal discomfort—Lomustine—brain cancer	0.0139	0.0292	CcSEcCtD
Isradipine—CACNA2D1—hindbrain—brain cancer	0.0119	0.0459	CbGeAlD
Isradipine—Oropharyngeal pain—Lomustine—brain cancer	0.0111	0.0234	CcSEcCtD
Isradipine—CACNA2D2—telencephalon—brain cancer	0.00845	0.0324	CbGeAlD
Isradipine—Visual disturbance—Lomustine—brain cancer	0.00775	0.0163	CcSEcCtD
Isradipine—Transient ischaemic attack—Temozolomide—brain cancer	0.00769	0.0162	CcSEcCtD
Isradipine—Lethargy—Lomustine—brain cancer	0.00749	0.0157	CcSEcCtD
Isradipine—Digestion impaired—Hydroxyurea—brain cancer	0.00743	0.0156	CcSEcCtD
Isradipine—Nocturia—Procarbazine—brain cancer	0.00692	0.0145	CcSEcCtD
Isradipine—CACNA2D2—pituitary gland—brain cancer	0.00688	0.0264	CbGeAlD
Isradipine—CACNA2D1—brainstem—brain cancer	0.00685	0.0263	CbGeAlD
Isradipine—CACNB2—telencephalon—brain cancer	0.00647	0.0248	CbGeAlD
Isradipine—CACNA2D2—midbrain—brain cancer	0.00607	0.0233	CbGeAlD
Isradipine—CACNA2D2—spinal cord—brain cancer	0.00592	0.0227	CbGeAlD
Isradipine—Digestion impaired—Temozolomide—brain cancer	0.00581	0.0122	CcSEcCtD
Isradipine—Gynaecomastia—Procarbazine—brain cancer	0.00575	0.0121	CcSEcCtD
Isradipine—CACNA1H—gonad—brain cancer	0.00572	0.022	CbGeAlD
Isradipine—CACNA1D—telencephalon—brain cancer	0.00565	0.0217	CbGeAlD
Isradipine—CACNA1H—pituitary gland—brain cancer	0.00558	0.0214	CbGeAlD
Isradipine—CACNA2D2—endocrine gland—brain cancer	0.00533	0.0205	CbGeAlD
Isradipine—CACNB2—pituitary gland—brain cancer	0.00527	0.0202	CbGeAlD
Isradipine—CACNA2D2—head—brain cancer	0.00526	0.0202	CbGeAlD
Isradipine—CACNA1C—telencephalon—brain cancer	0.00522	0.02	CbGeAlD
Isradipine—Visual impairment—Lomustine—brain cancer	0.00489	0.0103	CcSEcCtD
Isradipine—CACNA2D2—central nervous system—brain cancer	0.0048	0.0184	CbGeAlD
Isradipine—Lethargy—Procarbazine—brain cancer	0.00476	0.00999	CcSEcCtD
Isradipine—CACNA2D2—cerebellum—brain cancer	0.00469	0.018	CbGeAlD
Isradipine—CACNA1D—pituitary gland—brain cancer	0.0046	0.0177	CbGeAlD
Isradipine—CACNA1H—endocrine gland—brain cancer	0.00432	0.0166	CbGeAlD
Isradipine—CACNA1C—pituitary gland—brain cancer	0.00425	0.0163	CbGeAlD
Isradipine—Clevidipine—CYP2C9—brain cancer	0.00415	0.21	CrCbGaD
Isradipine—CACNB2—head—brain cancer	0.00403	0.0155	CbGeAlD
Isradipine—Leukopenia—Lomustine—brain cancer	0.00396	0.00832	CcSEcCtD
Isradipine—Angina pectoris—Procarbazine—brain cancer	0.00392	0.00825	CcSEcCtD
Isradipine—Tingling sensation—Etoposide—brain cancer	0.00386	0.00812	CcSEcCtD
Isradipine—CACNA2D1—endocrine gland—brain cancer	0.00383	0.0147	CbGeAlD
Isradipine—CACNA2D2—brain—brain cancer	0.00381	0.0146	CbGeAlD
Isradipine—CACNA1H—cerebellum—brain cancer	0.00381	0.0146	CbGeAlD
Isradipine—CACNA2D1—head—brain cancer	0.00378	0.0145	CbGeAlD
Isradipine—Numbness—Etoposide—brain cancer	0.00375	0.00787	CcSEcCtD
Isradipine—Nilvadipine—CYP2C9—brain cancer	0.00372	0.189	CrCbGaD
Isradipine—Pollakiuria—Procarbazine—brain cancer	0.00372	0.00782	CcSEcCtD
Isradipine—Photosensitivity reaction—Procarbazine—brain cancer	0.00368	0.00773	CcSEcCtD
Isradipine—CACNB2—central nervous system—brain cancer	0.00368	0.0141	CbGeAlD
Isradipine—Gynaecomastia—Carmustine—brain cancer	0.00359	0.00755	CcSEcCtD
Isradipine—CACNB2—cerebellum—brain cancer	0.00359	0.0138	CbGeAlD
Isradipine—Drowsiness—Procarbazine—brain cancer	0.00359	0.00755	CcSEcCtD
Isradipine—Sensory loss—Etoposide—brain cancer	0.00359	0.00754	CcSEcCtD
Isradipine—CACNA1D—endocrine gland—brain cancer	0.00357	0.0137	CbGeAlD
Isradipine—Thrombocytopenia—Lomustine—brain cancer	0.00353	0.00742	CcSEcCtD
Isradipine—CACNA1D—head—brain cancer	0.00352	0.0135	CbGeAlD
Isradipine—CACNA2D1—central nervous system—brain cancer	0.00345	0.0133	CbGeAlD
Isradipine—CACNA2D1—cerebellum—brain cancer	0.00337	0.013	CbGeAlD
Isradipine—CACNA1C—endocrine gland—brain cancer	0.00329	0.0126	CbGeAlD
Isradipine—Breast disorder—Hydroxyurea—brain cancer	0.00326	0.00685	CcSEcCtD
Isradipine—CACNA1C—head—brain cancer	0.00325	0.0125	CbGeAlD
Isradipine—CACNA1D—central nervous system—brain cancer	0.00321	0.0123	CbGeAlD
Isradipine—Amlodipine—CYP2C9—brain cancer	0.00321	0.162	CrCbGaD
Isradipine—CACNA1D—cerebellum—brain cancer	0.00314	0.0121	CbGeAlD
Isradipine—Decreased appetite—Lomustine—brain cancer	0.00314	0.00659	CcSEcCtD
Isradipine—CACNA1H—brain—brain cancer	0.00309	0.0119	CbGeAlD
Isradipine—Flushing—Procarbazine—brain cancer	0.00299	0.00629	CcSEcCtD
Isradipine—CACNA1C—central nervous system—brain cancer	0.00297	0.0114	CbGeAlD
Isradipine—Felodipine—CYP2C9—brain cancer	0.00296	0.15	CrCbGaD
Isradipine—CACNB2—brain—brain cancer	0.00292	0.0112	CbGeAlD
Isradipine—CACNA1C—cerebellum—brain cancer	0.0029	0.0111	CbGeAlD
Isradipine—Nifedipine—CYP2C9—brain cancer	0.00287	0.145	CrCbGaD
Isradipine—Weight increased—Hydroxyurea—brain cancer	0.00284	0.00596	CcSEcCtD
Isradipine—Nicardipine—CYP2C9—brain cancer	0.00282	0.143	CrCbGaD
Isradipine—Drowsiness—Hydroxyurea—brain cancer	0.00278	0.00584	CcSEcCtD
Isradipine—Tension—Procarbazine—brain cancer	0.00275	0.00579	CcSEcCtD
Isradipine—CACNA2D1—brain—brain cancer	0.00274	0.0105	CbGeAlD
Isradipine—Nervousness—Procarbazine—brain cancer	0.00273	0.00573	CcSEcCtD
Isradipine—Liver function test abnormal—Carmustine—brain cancer	0.00269	0.00566	CcSEcCtD
Isradipine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00263	0.00552	CcSEcCtD
Isradipine—Anaemia—Procarbazine—brain cancer	0.00259	0.00545	CcSEcCtD
Isradipine—CACNA1D—brain—brain cancer	0.00255	0.0098	CbGeAlD
Isradipine—Breast disorder—Temozolomide—brain cancer	0.00255	0.00535	CcSEcCtD
Isradipine—Syncope—Procarbazine—brain cancer	0.00252	0.00529	CcSEcCtD
Isradipine—Leukopenia—Procarbazine—brain cancer	0.00251	0.00528	CcSEcCtD
Isradipine—Loss of consciousness—Procarbazine—brain cancer	0.00247	0.00518	CcSEcCtD
Isradipine—Cough—Procarbazine—brain cancer	0.00245	0.00515	CcSEcCtD
Isradipine—Arthralgia—Procarbazine—brain cancer	0.00239	0.00502	CcSEcCtD
Isradipine—Anxiety—Procarbazine—brain cancer	0.00238	0.005	CcSEcCtD
Isradipine—CACNA1C—brain—brain cancer	0.00236	0.00905	CbGeAlD
Isradipine—Dry mouth—Procarbazine—brain cancer	0.00234	0.00491	CcSEcCtD
Isradipine—Cardiac failure—Etoposide—brain cancer	0.00231	0.00486	CcSEcCtD
Isradipine—Vomiting—Lomustine—brain cancer	0.00229	0.00482	CcSEcCtD
Isradipine—Oedema—Procarbazine—brain cancer	0.00229	0.00481	CcSEcCtD
Isradipine—Angiopathy—Hydroxyurea—brain cancer	0.00226	0.00476	CcSEcCtD
Isradipine—Shock—Procarbazine—brain cancer	0.00225	0.00474	CcSEcCtD
Isradipine—Pollakiuria—Temozolomide—brain cancer	0.00225	0.00473	CcSEcCtD
Isradipine—Erectile dysfunction—Temozolomide—brain cancer	0.00224	0.00471	CcSEcCtD
Isradipine—Thrombocytopenia—Procarbazine—brain cancer	0.00224	0.00471	CcSEcCtD
Isradipine—Depression—Carmustine—brain cancer	0.00224	0.00471	CcSEcCtD
Isradipine—Tachycardia—Procarbazine—brain cancer	0.00224	0.0047	CcSEcCtD
Isradipine—Photosensitivity reaction—Temozolomide—brain cancer	0.00222	0.00467	CcSEcCtD
Isradipine—Weight increased—Temozolomide—brain cancer	0.00222	0.00466	CcSEcCtD
Isradipine—Hyperhidrosis—Procarbazine—brain cancer	0.00221	0.00465	CcSEcCtD
Isradipine—Depression—Temozolomide—brain cancer	0.00217	0.00455	CcSEcCtD
Isradipine—Nausea—Lomustine—brain cancer	0.00214	0.0045	CcSEcCtD
Isradipine—Hypotension—Procarbazine—brain cancer	0.00214	0.0045	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00209	0.00439	CcSEcCtD
Isradipine—Insomnia—Procarbazine—brain cancer	0.00207	0.00435	CcSEcCtD
Isradipine—Paraesthesia—Procarbazine—brain cancer	0.00206	0.00432	CcSEcCtD
Isradipine—Hepatobiliary disease—Temozolomide—brain cancer	0.00205	0.00432	CcSEcCtD
Isradipine—Somnolence—Procarbazine—brain cancer	0.00204	0.00428	CcSEcCtD
Isradipine—Cramp muscle—Etoposide—brain cancer	0.00203	0.00427	CcSEcCtD
Isradipine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00202	0.00424	CcSEcCtD
Isradipine—Anaemia—Hydroxyurea—brain cancer	0.00201	0.00422	CcSEcCtD
Isradipine—Hypoaesthesia—Carmustine—brain cancer	0.00201	0.00422	CcSEcCtD
Isradipine—Decreased appetite—Procarbazine—brain cancer	0.00199	0.00418	CcSEcCtD
Isradipine—Oedema peripheral—Carmustine—brain cancer	0.00199	0.00418	CcSEcCtD
Isradipine—Connective tissue disorder—Carmustine—brain cancer	0.00198	0.00417	CcSEcCtD
Isradipine—Fatigue—Procarbazine—brain cancer	0.00198	0.00415	CcSEcCtD
Isradipine—Malaise—Hydroxyurea—brain cancer	0.00196	0.00412	CcSEcCtD
Isradipine—Constipation—Procarbazine—brain cancer	0.00196	0.00412	CcSEcCtD
Isradipine—Hepatitis—Temozolomide—brain cancer	0.00195	0.0041	CcSEcCtD
Isradipine—Leukopenia—Hydroxyurea—brain cancer	0.00194	0.00409	CcSEcCtD
Isradipine—Visual impairment—Carmustine—brain cancer	0.00194	0.00409	CcSEcCtD
Isradipine—Hypoaesthesia—Temozolomide—brain cancer	0.00194	0.00408	CcSEcCtD
Isradipine—Urinary tract disorder—Temozolomide—brain cancer	0.00193	0.00405	CcSEcCtD
Isradipine—Oedema peripheral—Temozolomide—brain cancer	0.00192	0.00404	CcSEcCtD
Isradipine—Connective tissue disorder—Temozolomide—brain cancer	0.00192	0.00403	CcSEcCtD
Isradipine—Urethral disorder—Temozolomide—brain cancer	0.00191	0.00402	CcSEcCtD
Isradipine—Feeling abnormal—Procarbazine—brain cancer	0.00189	0.00397	CcSEcCtD
Isradipine—Eye disorder—Carmustine—brain cancer	0.00189	0.00396	CcSEcCtD
Isradipine—Visual impairment—Temozolomide—brain cancer	0.00188	0.00395	CcSEcCtD
Isradipine—Flushing—Carmustine—brain cancer	0.00187	0.00393	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00184	0.00386	CcSEcCtD
Isradipine—Discomfort—Hydroxyurea—brain cancer	0.00183	0.00384	CcSEcCtD
Isradipine—Eye disorder—Temozolomide—brain cancer	0.00182	0.00383	CcSEcCtD
Isradipine—Urticaria—Procarbazine—brain cancer	0.00182	0.00382	CcSEcCtD
Isradipine—Flushing—Temozolomide—brain cancer	0.00181	0.0038	CcSEcCtD
Isradipine—Cardiac disorder—Temozolomide—brain cancer	0.00181	0.0038	CcSEcCtD
Isradipine—Oedema—Hydroxyurea—brain cancer	0.00177	0.00373	CcSEcCtD
Isradipine—Angiopathy—Temozolomide—brain cancer	0.00177	0.00372	CcSEcCtD
Isradipine—Mental disorder—Carmustine—brain cancer	0.00177	0.00371	CcSEcCtD
Isradipine—Immune system disorder—Temozolomide—brain cancer	0.00176	0.0037	CcSEcCtD
Isradipine—Mediastinal disorder—Temozolomide—brain cancer	0.00176	0.00369	CcSEcCtD
Isradipine—Malnutrition—Carmustine—brain cancer	0.00176	0.00369	CcSEcCtD
Isradipine—Nervous system disorder—Hydroxyurea—brain cancer	0.00174	0.00365	CcSEcCtD
Isradipine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00174	0.00365	CcSEcCtD
Isradipine—Skin disorder—Hydroxyurea—brain cancer	0.00172	0.00362	CcSEcCtD
Isradipine—Acute coronary syndrome—Etoposide—brain cancer	0.00171	0.0036	CcSEcCtD
Isradipine—Mental disorder—Temozolomide—brain cancer	0.00171	0.00359	CcSEcCtD
Isradipine—Myocardial infarction—Etoposide—brain cancer	0.0017	0.00358	CcSEcCtD
Isradipine—Back pain—Carmustine—brain cancer	0.0017	0.00357	CcSEcCtD
Isradipine—Malnutrition—Temozolomide—brain cancer	0.0017	0.00357	CcSEcCtD
Isradipine—Vision blurred—Carmustine—brain cancer	0.00166	0.00348	CcSEcCtD
Isradipine—Asthenia—Procarbazine—brain cancer	0.00164	0.00345	CcSEcCtD
Isradipine—Hepatobiliary disease—Etoposide—brain cancer	0.00164	0.00345	CcSEcCtD
Isradipine—Back pain—Temozolomide—brain cancer	0.00164	0.00345	CcSEcCtD
Isradipine—Anaemia—Carmustine—brain cancer	0.00162	0.00341	CcSEcCtD
Isradipine—Pruritus—Procarbazine—brain cancer	0.00162	0.00341	CcSEcCtD
Isradipine—Vision blurred—Temozolomide—brain cancer	0.0016	0.00336	CcSEcCtD
Isradipine—Dyspnoea—Hydroxyurea—brain cancer	0.00158	0.00332	CcSEcCtD
Isradipine—Somnolence—Hydroxyurea—brain cancer	0.00158	0.00331	CcSEcCtD
Isradipine—Ill-defined disorder—Temozolomide—brain cancer	0.00157	0.00331	CcSEcCtD
Isradipine—Leukopenia—Carmustine—brain cancer	0.00157	0.0033	CcSEcCtD
Isradipine—Anaemia—Temozolomide—brain cancer	0.00157	0.0033	CcSEcCtD
Isradipine—Diarrhoea—Procarbazine—brain cancer	0.00157	0.00329	CcSEcCtD
Isradipine—Dyspepsia—Hydroxyurea—brain cancer	0.00156	0.00328	CcSEcCtD
Isradipine—Hypoaesthesia—Etoposide—brain cancer	0.00155	0.00326	CcSEcCtD
Isradipine—Angioedema—Temozolomide—brain cancer	0.00155	0.00326	CcSEcCtD
Isradipine—Decreased appetite—Hydroxyurea—brain cancer	0.00154	0.00324	CcSEcCtD
Isradipine—Urinary tract disorder—Etoposide—brain cancer	0.00154	0.00324	CcSEcCtD
Isradipine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00153	0.00322	CcSEcCtD
Isradipine—Malaise—Temozolomide—brain cancer	0.00153	0.00322	CcSEcCtD
Isradipine—Urethral disorder—Etoposide—brain cancer	0.00153	0.00321	CcSEcCtD
Isradipine—Fatigue—Hydroxyurea—brain cancer	0.00153	0.00321	CcSEcCtD
Isradipine—Leukopenia—Temozolomide—brain cancer	0.00152	0.00319	CcSEcCtD
Isradipine—Constipation—Hydroxyurea—brain cancer	0.00152	0.00319	CcSEcCtD
Isradipine—Dizziness—Procarbazine—brain cancer	0.00151	0.00318	CcSEcCtD
Isradipine—Palpitations—Temozolomide—brain cancer	0.0015	0.00315	CcSEcCtD
Isradipine—Chest pain—Carmustine—brain cancer	0.0015	0.00314	CcSEcCtD
Isradipine—Anxiety—Carmustine—brain cancer	0.00149	0.00313	CcSEcCtD
Isradipine—Cough—Temozolomide—brain cancer	0.00148	0.00311	CcSEcCtD
Isradipine—Feeling abnormal—Hydroxyurea—brain cancer	0.00146	0.00307	CcSEcCtD
Isradipine—Eye disorder—Etoposide—brain cancer	0.00146	0.00306	CcSEcCtD
Isradipine—Vomiting—Procarbazine—brain cancer	0.00146	0.00306	CcSEcCtD
Isradipine—Flushing—Etoposide—brain cancer	0.00145	0.00304	CcSEcCtD
Isradipine—Cardiac disorder—Etoposide—brain cancer	0.00145	0.00304	CcSEcCtD
Isradipine—Arthralgia—Temozolomide—brain cancer	0.00144	0.00304	CcSEcCtD
Isradipine—Rash—Procarbazine—brain cancer	0.00144	0.00304	CcSEcCtD
Isradipine—Dermatitis—Procarbazine—brain cancer	0.00144	0.00303	CcSEcCtD
Isradipine—Anxiety—Temozolomide—brain cancer	0.00144	0.00303	CcSEcCtD
Isradipine—Headache—Procarbazine—brain cancer	0.00144	0.00302	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00143	0.00302	CcSEcCtD
Isradipine—Oedema—Carmustine—brain cancer	0.00143	0.00301	CcSEcCtD
Isradipine—Discomfort—Temozolomide—brain cancer	0.00143	0.003	CcSEcCtD
Isradipine—Angiopathy—Etoposide—brain cancer	0.00142	0.00297	CcSEcCtD
Isradipine—Dry mouth—Temozolomide—brain cancer	0.00141	0.00297	CcSEcCtD
Isradipine—Immune system disorder—Etoposide—brain cancer	0.00141	0.00296	CcSEcCtD
Isradipine—Mediastinal disorder—Etoposide—brain cancer	0.00141	0.00295	CcSEcCtD
Isradipine—Thrombocytopenia—Carmustine—brain cancer	0.0014	0.00295	CcSEcCtD
Isradipine—Tachycardia—Carmustine—brain cancer	0.0014	0.00294	CcSEcCtD
Isradipine—Anaphylactic shock—Temozolomide—brain cancer	0.00139	0.00291	CcSEcCtD
Isradipine—Oedema—Temozolomide—brain cancer	0.00139	0.00291	CcSEcCtD
Isradipine—Nausea—Procarbazine—brain cancer	0.00136	0.00286	CcSEcCtD
Isradipine—Nervous system disorder—Temozolomide—brain cancer	0.00136	0.00285	CcSEcCtD
Isradipine—Thrombocytopenia—Temozolomide—brain cancer	0.00136	0.00285	CcSEcCtD
Isradipine—Skin disorder—Temozolomide—brain cancer	0.00135	0.00283	CcSEcCtD
Isradipine—Hypotension—Carmustine—brain cancer	0.00134	0.00281	CcSEcCtD
Isradipine—Hyperhidrosis—Temozolomide—brain cancer	0.00134	0.00281	CcSEcCtD
Isradipine—Back pain—Etoposide—brain cancer	0.00131	0.00276	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00131	0.00274	CcSEcCtD
Isradipine—Muscle spasms—Etoposide—brain cancer	0.00131	0.00274	CcSEcCtD
Isradipine—Insomnia—Carmustine—brain cancer	0.0013	0.00272	CcSEcCtD
Isradipine—Paraesthesia—Carmustine—brain cancer	0.00129	0.0027	CcSEcCtD
Isradipine—Dyspnoea—Carmustine—brain cancer	0.00128	0.00269	CcSEcCtD
Isradipine—Somnolence—Carmustine—brain cancer	0.00127	0.00268	CcSEcCtD
Isradipine—Asthenia—Hydroxyurea—brain cancer	0.00127	0.00267	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00126	0.00265	CcSEcCtD
Isradipine—Ill-defined disorder—Etoposide—brain cancer	0.00126	0.00265	CcSEcCtD
Isradipine—Anaemia—Etoposide—brain cancer	0.00126	0.00264	CcSEcCtD
Isradipine—Insomnia—Temozolomide—brain cancer	0.00125	0.00263	CcSEcCtD
Isradipine—Decreased appetite—Carmustine—brain cancer	0.00125	0.00262	CcSEcCtD
Isradipine—Paraesthesia—Temozolomide—brain cancer	0.00124	0.00261	CcSEcCtD
Isradipine—Gastrointestinal disorder—Carmustine—brain cancer	0.00124	0.0026	CcSEcCtD
Isradipine—Dyspnoea—Temozolomide—brain cancer	0.00123	0.00259	CcSEcCtD
Isradipine—Somnolence—Temozolomide—brain cancer	0.00123	0.00259	CcSEcCtD
Isradipine—Constipation—Carmustine—brain cancer	0.00123	0.00258	CcSEcCtD
Isradipine—Malaise—Etoposide—brain cancer	0.00122	0.00257	CcSEcCtD
Isradipine—Dyspepsia—Temozolomide—brain cancer	0.00122	0.00256	CcSEcCtD
Isradipine—Leukopenia—Etoposide—brain cancer	0.00122	0.00255	CcSEcCtD
Isradipine—CYP3A4—endocrine gland—brain cancer	0.00122	0.00467	CbGeAlD
Isradipine—Diarrhoea—Hydroxyurea—brain cancer	0.00121	0.00255	CcSEcCtD
Isradipine—Decreased appetite—Temozolomide—brain cancer	0.0012	0.00253	CcSEcCtD
Isradipine—Gastrointestinal disorder—Temozolomide—brain cancer	0.0012	0.00251	CcSEcCtD
Isradipine—Fatigue—Temozolomide—brain cancer	0.00119	0.00251	CcSEcCtD
Isradipine—Loss of consciousness—Etoposide—brain cancer	0.00119	0.00251	CcSEcCtD
Isradipine—Cough—Etoposide—brain cancer	0.00119	0.00249	CcSEcCtD
Isradipine—Constipation—Temozolomide—brain cancer	0.00118	0.00249	CcSEcCtD
Isradipine—Feeling abnormal—Carmustine—brain cancer	0.00118	0.00248	CcSEcCtD
Isradipine—Dizziness—Hydroxyurea—brain cancer	0.00117	0.00246	CcSEcCtD
Isradipine—Chest pain—Etoposide—brain cancer	0.00116	0.00243	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00115	0.00241	CcSEcCtD
Isradipine—Discomfort—Etoposide—brain cancer	0.00114	0.0024	CcSEcCtD
Isradipine—Feeling abnormal—Temozolomide—brain cancer	0.00114	0.0024	CcSEcCtD
Isradipine—Vomiting—Hydroxyurea—brain cancer	0.00113	0.00237	CcSEcCtD
Isradipine—Rash—Hydroxyurea—brain cancer	0.00112	0.00235	CcSEcCtD
Isradipine—Dermatitis—Hydroxyurea—brain cancer	0.00112	0.00235	CcSEcCtD
Isradipine—Headache—Hydroxyurea—brain cancer	0.00111	0.00233	CcSEcCtD
Isradipine—Anaphylactic shock—Etoposide—brain cancer	0.00111	0.00233	CcSEcCtD
Isradipine—Urticaria—Temozolomide—brain cancer	0.0011	0.00231	CcSEcCtD
Isradipine—CYP3A4—central nervous system—brain cancer	0.0011	0.00421	CbGeAlD
Isradipine—Thrombocytopenia—Etoposide—brain cancer	0.00109	0.00228	CcSEcCtD
Isradipine—Tachycardia—Etoposide—brain cancer	0.00108	0.00227	CcSEcCtD
Isradipine—Skin disorder—Etoposide—brain cancer	0.00108	0.00226	CcSEcCtD
Isradipine—Hyperhidrosis—Etoposide—brain cancer	0.00107	0.00225	CcSEcCtD
Isradipine—Nausea—Hydroxyurea—brain cancer	0.00105	0.00221	CcSEcCtD
Isradipine—Hypotension—Etoposide—brain cancer	0.00104	0.00218	CcSEcCtD
Isradipine—Asthenia—Carmustine—brain cancer	0.00103	0.00216	CcSEcCtD
Isradipine—Paraesthesia—Etoposide—brain cancer	0.000995	0.00209	CcSEcCtD
Isradipine—Asthenia—Temozolomide—brain cancer	0.000994	0.00209	CcSEcCtD
Isradipine—Dyspnoea—Etoposide—brain cancer	0.000988	0.00208	CcSEcCtD
Isradipine—Somnolence—Etoposide—brain cancer	0.000985	0.00207	CcSEcCtD
Isradipine—Diarrhoea—Carmustine—brain cancer	0.000981	0.00206	CcSEcCtD
Isradipine—Pruritus—Temozolomide—brain cancer	0.00098	0.00206	CcSEcCtD
Isradipine—Decreased appetite—Etoposide—brain cancer	0.000963	0.00202	CcSEcCtD
Isradipine—Gastrointestinal disorder—Etoposide—brain cancer	0.000957	0.00201	CcSEcCtD
Isradipine—Fatigue—Etoposide—brain cancer	0.000956	0.00201	CcSEcCtD
Isradipine—Dizziness—Carmustine—brain cancer	0.000948	0.00199	CcSEcCtD
Isradipine—Constipation—Etoposide—brain cancer	0.000948	0.00199	CcSEcCtD
Isradipine—Diarrhoea—Temozolomide—brain cancer	0.000948	0.00199	CcSEcCtD
Isradipine—Dizziness—Temozolomide—brain cancer	0.000916	0.00192	CcSEcCtD
Isradipine—Feeling abnormal—Etoposide—brain cancer	0.000913	0.00192	CcSEcCtD
Isradipine—Vomiting—Carmustine—brain cancer	0.000911	0.00191	CcSEcCtD
Isradipine—Rash—Carmustine—brain cancer	0.000904	0.0019	CcSEcCtD
Isradipine—Dermatitis—Carmustine—brain cancer	0.000903	0.0019	CcSEcCtD
Isradipine—Headache—Carmustine—brain cancer	0.000898	0.00189	CcSEcCtD
Isradipine—Vomiting—Temozolomide—brain cancer	0.000881	0.00185	CcSEcCtD
Isradipine—Urticaria—Etoposide—brain cancer	0.000881	0.00185	CcSEcCtD
Isradipine—Rash—Temozolomide—brain cancer	0.000873	0.00184	CcSEcCtD
Isradipine—Dermatitis—Temozolomide—brain cancer	0.000873	0.00183	CcSEcCtD
Isradipine—Headache—Temozolomide—brain cancer	0.000868	0.00182	CcSEcCtD
Isradipine—Nausea—Carmustine—brain cancer	0.000851	0.00179	CcSEcCtD
Isradipine—Nausea—Temozolomide—brain cancer	0.000823	0.00173	CcSEcCtD
Isradipine—Asthenia—Etoposide—brain cancer	0.000795	0.00167	CcSEcCtD
Isradipine—Pruritus—Etoposide—brain cancer	0.000784	0.00165	CcSEcCtD
Isradipine—Diarrhoea—Etoposide—brain cancer	0.000758	0.00159	CcSEcCtD
Isradipine—Dizziness—Etoposide—brain cancer	0.000733	0.00154	CcSEcCtD
Isradipine—Vomiting—Etoposide—brain cancer	0.000705	0.00148	CcSEcCtD
Isradipine—Rash—Etoposide—brain cancer	0.000699	0.00147	CcSEcCtD
Isradipine—Dermatitis—Etoposide—brain cancer	0.000698	0.00147	CcSEcCtD
Isradipine—Headache—Etoposide—brain cancer	0.000694	0.00146	CcSEcCtD
Isradipine—Nausea—Etoposide—brain cancer	0.000658	0.00138	CcSEcCtD
